Cost-Effectiveness of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Or 4 Chronic Hepatitis C in England and Wales
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1508
https://www.valueinhealthjournal.com/article/S1098-3015(15)03584-6/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1411
First Page :
A589
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03584-6&doi=10.1016/j.jval.2015.09.1508